Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
XEN-45 demonstrates a favourable safety and efficacy profile for glaucoma secondary to FUS and IU. However, its efficacy is significantly poor for JIA-related uveitic glaucoma.
Authors
- Bogomil Voykov (ORCID: https://orcid.org/0000-0002-1706-126X)
- Deshka Doycheva
- David A. Merle (ORCID: https://orcid.org/0000-0003-4485-5580)
- Caroline J. Gassel (ORCID: https://orcid.org/0000-0001-6718-7883)
- Emil Nasyrov (ORCID: https://orcid.org/0009-0009-3375-702X)
Institutions
- STZ eyetrial (DE)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1080/09273948.2024.2423197
- Citations
- 2
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.08